{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:59:11Z","timestamp":1785380351263,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA095039"],"award-info":[{"award-number":["R01 CA095039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA095039"],"award-info":[{"award-number":["R01 CA095039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA095039"],"award-info":[{"award-number":["R01 CA095039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA095039"],"award-info":[{"award-number":["R01 CA095039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics & Chromatin"],"DOI":"10.1186\/s13072-025-00617-2","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T03:45:51Z","timestamp":1754883951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["TET1 functions as a tumor suppressor in lung adenocarcinoma through epigenetic remodeling and immune modulation"],"prefix":"10.1186","volume":"18","author":[{"given":"Abdur","family":"Rahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Ruis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Rajczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica E.","family":"Kruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Y.","family":"Tretyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"5532","key":"617_CR1","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1126\/science.1063852","volume":"293","author":"PA Jones","year":"2001","unstructured":"Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001;293(5532):1068\u201370.","journal-title":"Science"},{"issue":"6","key":"617_CR2","first-page":"866","volume":"146","author":"N Bhutani","year":"2011","unstructured":"Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell. 2011;146(6):866\u201372.","journal-title":"DNA Demethylation Dynamics Cell"},{"issue":"7","key":"617_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1039\/c4mb00150h","volume":"10","author":"D Ji","year":"2014","unstructured":"Ji D, et al. Effects of Tet-induced oxidation products of 5-methylcytosine on Dnmt1- and DNMT3a-mediated cytosine methylation. Mol Biosyst. 2014;10(7):1749\u201352.","journal-title":"Mol Biosyst"},{"issue":"2","key":"617_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0959-437X(93)90027-M","volume":"3","author":"PH Tate","year":"1993","unstructured":"Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev. 1993;3(2):226\u201331.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"617_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13148-022-01382-9","volume":"14","author":"Q Wang","year":"2022","unstructured":"Wang Q, et al. Gene body methylation in cancer: molecular mechanisms and clinical applications. Clin Epigenetics. 2022;14(1):154.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"617_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/561","volume":"19","author":"PL Jones","year":"1998","unstructured":"Jones PL, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998;19(2):187\u201391.","journal-title":"Nat Genet"},{"issue":"7","key":"617_CR7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.cell.2012.11.022","volume":"151","author":"M Mell\u00e9n","year":"2012","unstructured":"Mell\u00e9n M, et al. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. 2012;151(7):1417\u201330.","journal-title":"Cell"},{"issue":"6047","key":"617_CR8","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito S, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333(6047):1300\u20133.","journal-title":"Science"},{"issue":"5929","key":"617_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930\u20135.","journal-title":"Science"},{"issue":"7447","key":"617_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature12052","volume":"497","author":"M Ko","year":"2013","unstructured":"Ko M, et al. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature. 2013;497(7447):122\u20136.","journal-title":"Nature"},{"issue":"6","key":"617_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cell.2012.11.014","volume":"151","author":"Y Xu","year":"2012","unstructured":"Xu Y, et al. Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for xenopus eye and neural development. Cell. 2012;151(6):1200\u201313.","journal-title":"Cell"},{"issue":"7347","key":"617_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature09934","volume":"473","author":"H Wu","year":"2011","unstructured":"Wu H, et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature. 2011;473(7347):389\u201393.","journal-title":"Nature"},{"issue":"4","key":"617_CR13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1322921111","volume":"111","author":"Y Huang","year":"2014","unstructured":"Huang Y, et al. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells. Proc Natl Acad Sci. 2014;111(4):1361\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"617_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/onc.2012.67","volume":"32","author":"H Yang","year":"2013","unstructured":"Yang H, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene. 2013;32(5):663\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"617_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/embor.2011.233","volume":"13","author":"K Williams","year":"2012","unstructured":"Williams K, Christensen J, Helin K. DNA methylation: TET proteins\u2014guardians of CpG islands? EMBO Rep. 2012;13(1):28\u201335.","journal-title":"EMBO Rep"},{"key":"617_CR16","doi-asserted-by":"crossref","unstructured":"Bensberg M et al. TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2021;118(34).","DOI":"10.1073\/pnas.2110758118"},{"issue":"1","key":"617_CR17","doi-asserted-by":"publisher","first-page":"10071","DOI":"10.1038\/ncomms10071","volume":"6","author":"J An","year":"2015","unstructured":"An J, et al. Acute loss of TET function results in aggressive myeloid cancer in mice. Nat Commun. 2015;6(1):10071.","journal-title":"Nat Commun"},{"issue":"6","key":"617_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/ni.3148","volume":"16","author":"L Cimmino","year":"2015","unstructured":"Cimmino L, et al. TET1 is a tumor suppressor of hematopoietic malignancy. Nat Immunol. 2015;16(6):653\u201362.","journal-title":"Nat Immunol"},{"key":"617_CR19","doi-asserted-by":"crossref","unstructured":"Qi J et al. Targeting Wnt\/\u03b2-Catenin signaling by TET1\/FOXO4 inhibits metastatic spreading and self-renewal of cancer stem cells in gastric cancer. Cancers (Basel). 2022;14(13).","DOI":"10.3390\/cancers14133232"},{"issue":"12","key":"617_CR20","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1541-7786.MCR-20-0359","volume":"18","author":"B Bao","year":"2020","unstructured":"Bao B, et al. Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer. Mol Cancer Res. 2020;18(12):1803\u201314.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"617_CR21","doi-asserted-by":"publisher","first-page":"2323751","DOI":"10.1080\/15592294.2024.2323751","volume":"19","author":"J Ren","year":"2024","unstructured":"Ren J, et al. TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy. Epigenetics. 2024;19(1):2323751.","journal-title":"Epigenetics"},{"issue":"29","key":"617_CR22","doi-asserted-by":"publisher","first-page":"11994","DOI":"10.1073\/pnas.1310656110","volume":"110","author":"H Huang","year":"2013","unstructured":"Huang H, et al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2013;110(29):11994\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"617_CR23","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/0008-5472.CAN-17-2082","volume":"78","author":"CR Good","year":"2018","unstructured":"Good CR, et al. TET1-mediated hypomethylation activates oncogenic signaling in triple-negative breast cancer. Cancer Res. 2018;78(15):4126\u201337.","journal-title":"Cancer Res"},{"issue":"20","key":"617_CR24","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41388-023-02659-w","volume":"42","author":"Q Yang","year":"2023","unstructured":"Yang Q, et al. Hypoxia switches TET1 from being tumor-suppressive to oncogenic. Oncogene. 2023;42(20):1634\u201348.","journal-title":"Oncogene"},{"issue":"8","key":"617_CR25","first-page":"470","volume":"18","author":"P Sidaway","year":"2021","unstructured":"Sidaway P. Sotorasib effective in KRAS-mutant NSCLC. Nat Reviews Clin Oncol. 2021;18(8):470\u2013470.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"1","key":"617_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.trsl.2014.03.001","volume":"165","author":"SM Langevin","year":"2015","unstructured":"Langevin SM, Kratzke RA, Kelsey KT. Epigenetics of lung cancer. Transl Res. 2015;165(1):74\u201390.","journal-title":"Transl Res"},{"issue":"5","key":"617_CR27","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/cncr.22087","volume":"107","author":"H Kim","year":"2006","unstructured":"Kim H, et al. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Cancer. 2006;107(5):1042\u20139.","journal-title":"Cancer"},{"issue":"2","key":"617_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.lungcan.2006.10.022","volume":"55","author":"RK Lin","year":"2007","unstructured":"Lin RK, et al. Alteration of DNA methyltransferases contributes to 5\u2019cpg methylation and poor prognosis in lung cancer. Lung Cancer. 2007;55(2):205\u201313.","journal-title":"Lung Cancer"},{"key":"617_CR29","doi-asserted-by":"crossref","unstructured":"Ferrone CK, Blydt-Hansen M, Rauh MJ. Age-associated TET2 mutations: common drivers of myeloid dysfunction, cancer and cardiovascular disease. Int J Mol Sci. 2020;21(2).","DOI":"10.3390\/ijms21020626"},{"key":"617_CR30","doi-asserted-by":"crossref","unstructured":"Xu Q et al. Loss of TET reprograms Wnt signaling through impaired demethylation to promote lung cancer development. Proc Natl Acad Sci U S A. 2022;119(6).","DOI":"10.1073\/pnas.2107599119"},{"key":"617_CR31","doi-asserted-by":"publisher","first-page":"1418456","DOI":"10.3389\/fphar.2024.1418456","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, et al. Pan-cancer analyses reveal the molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic target. Front Pharmacol. 2024;15:1418456.","journal-title":"Front Pharmacol"},{"key":"617_CR32","doi-asserted-by":"crossref","unstructured":"Chen HQ et al. Epigenetic silencing of TET1 mediated hydroxymethylation of base excision repair pathway during lung carcinogenesis. Environ Pollut. 2021;268(Pt B):115860.","DOI":"10.1016\/j.envpol.2020.115860"},{"issue":"1","key":"617_CR33","doi-asserted-by":"publisher","first-page":"26591","DOI":"10.1038\/srep26591","volume":"6","author":"L Li","year":"2016","unstructured":"Li L, et al. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers. Sci Rep. 2016;6(1):26591.","journal-title":"Sci Rep"},{"issue":"8","key":"617_CR34","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1158\/0008-5472.CAN-18-1234","volume":"79","author":"PT Filipczak","year":"2019","unstructured":"Filipczak PT, et al. p53-Suppressed oncogene TET1 prevents cellular aging in lung cancer. Cancer Res. 2019;79(8):1758\u201368.","journal-title":"Cancer Res"},{"issue":"6","key":"617_CR35","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","volume":"150","author":"CG Lian","year":"2012","unstructured":"Lian CG, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012;150(6):1135\u201346.","journal-title":"Cell"},{"issue":"1","key":"617_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.21873\/invivo.13098","volume":"37","author":"AA Alrehaili","year":"2023","unstructured":"Alrehaili AA, et al. Evaluation of TET family gene expression and 5-hydroxymethylcytosine as potential epigenetic markers in non-small cell lung cancer. Vivo. 2023;37(1):445\u201353.","journal-title":"Vivo"},{"issue":"2","key":"617_CR37","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10637-010-9610-4","volume":"30","author":"K Sahoo","year":"2012","unstructured":"Sahoo K, et al. The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress. Invest New Drugs. 2012;30(2):558\u201367.","journal-title":"Invest New Drugs"},{"issue":"3","key":"617_CR38","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/mp4006535","volume":"11","author":"JJ Salomon","year":"2014","unstructured":"Salomon JJ, et al. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier. Mol Pharm. 2014;11(3):995\u20131006.","journal-title":"Mol Pharm"},{"key":"617_CR39","doi-asserted-by":"crossref","unstructured":"Kong LR et al. Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation. Nat Commun. 2020;11(1):2086.","DOI":"10.1038\/s41467-020-15608-y"},{"issue":"2","key":"617_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1124\/molpharm.121.000254","volume":"100","author":"TK Hinz","year":"2021","unstructured":"Hinz TK, et al. TP53 null mutations identify lung cancer cell lines with highest sensitivity to the nontaxane microtubule inhibitor eribulin. Mol Pharmacol. 2021;100(2):144\u201354.","journal-title":"Mol Pharmacol"},{"issue":"11","key":"617_CR41","doi-asserted-by":"publisher","first-page":"12426","DOI":"10.18632\/oncotarget.6998","volume":"7","author":"CA Vaughan","year":"2016","unstructured":"Vaughan CA, et al. Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter. Oncotarget. 2016;7(11):12426\u201346.","journal-title":"Oncotarget"},{"key":"617_CR42","doi-asserted-by":"publisher","first-page":"216154","DOI":"10.1016\/j.canlet.2023.216154","volume":"562","author":"R Feng","year":"2023","unstructured":"Feng R, et al. Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression. Cancer Lett. 2023;562:216154.","journal-title":"Cancer Lett"},{"issue":"14","key":"617_CR43","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1101\/gad.1935210","volume":"24","author":"M Dejosez","year":"2010","unstructured":"Dejosez M, et al. Ronin\/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells. Genes Dev. 2010;24(14):1479\u201384.","journal-title":"Genes Dev"},{"issue":"5","key":"617_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1021\/acs.chemrestox.9b00015","volume":"32","author":"CL Seiler","year":"2019","unstructured":"Seiler CL, et al. Epigenetic changes in alveolar type II lung cells of A\/J mice following intranasal treatment with lipopolysaccharide. Chem Res Toxicol. 2019;32(5):831\u20139.","journal-title":"Chem Res Toxicol"},{"issue":"24","key":"617_CR45","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1128\/JVI.01682-12","volume":"86","author":"J Verhelst","year":"2012","unstructured":"Verhelst J, et al. Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly. J Virol. 2012;86(24):13445\u201355.","journal-title":"J Virol"},{"issue":"36","key":"617_CR46","doi-asserted-by":"publisher","first-page":"25535","DOI":"10.1074\/jbc.274.36.25535","volume":"274","author":"SN Sarkar","year":"1999","unstructured":"Sarkar SN, et al. The nature of the catalytic domain of 2\u2019-5\u2019-oligoadenylate synthetases. J Biol Chem. 1999;274(36):25535\u201342.","journal-title":"J Biol Chem"},{"issue":"1","key":"617_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/jir.2010.0107","volume":"31","author":"H Kristiansen","year":"2011","unstructured":"Kristiansen H, et al. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res. 2011;31(1):41\u20137.","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"617_CR48","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1074\/jbc.274.3.1848","volume":"274","author":"SN Sarkar","year":"1999","unstructured":"Sarkar SN, et al. Enzymatic characteristics of recombinant medium isozyme of 2\u2019-5\u2019 oligoadenylate synthetase. J Biol Chem. 1999;274(3):1848\u201355.","journal-title":"J Biol Chem"},{"key":"617_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.virusres.2019.01.014","volume":"263","author":"C Kurokawa","year":"2019","unstructured":"Kurokawa C, Iankov ID, Galanis E. A key anti-viral protein, RSAD2\/VIPERIN, restricts the release of measles virus from infected cells. Virus Res. 2019;263:145\u201350.","journal-title":"Virus Res"},{"issue":"1\u20132","key":"617_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11010-005-9094-2","volume":"286","author":"Y Xia","year":"2006","unstructured":"Xia Y, et al. Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP. Mol Cell Biochem. 2006;286(1\u20132):67\u201376.","journal-title":"Mol Cell Biochem"},{"issue":"14","key":"617_CR51","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.18632\/oncotarget.2114","volume":"5","author":"LM Zhu","year":"2014","unstructured":"Zhu LM, et al. Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma. Oncotarget. 2014;5(14):5403\u201315.","journal-title":"Oncotarget"},{"issue":"11","key":"617_CR52","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","volume":"29","author":"X Wang","year":"2008","unstructured":"Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin. 2008;29(11):1275\u201388.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"617_CR53","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1(4):a000034.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"617_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","volume":"34","author":"SC Sun","year":"2013","unstructured":"Sun SC, Chang JH, Jin J. Regulation of nuclear factor-\u03baB in autoimmunity. Trends Immunol. 2013;34(6):282\u20139.","journal-title":"Trends Immunol"},{"issue":"8","key":"617_CR55","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41418-022-00938-9","volume":"29","author":"X Li","year":"2022","unstructured":"Li X, et al. Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3\/MLKL to prevent lymphopenia. Cell Death Differ. 2022;29(8):1500\u201312.","journal-title":"Cell Death Differ"},{"issue":"2","key":"617_CR56","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.bbrc.2007.08.183","volume":"363","author":"M Jang","year":"2007","unstructured":"Jang M, et al. Caspase-7 mediated cleavage of proteasome subunits during apoptosis. Biochem Biophys Res Commun. 2007;363(2):388\u201394.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7614","key":"617_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature18954","volume":"536","author":"AS Lee","year":"2016","unstructured":"Lee AS, et al. eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation. Nature. 2016;536(7614):96\u20139.","journal-title":"Nature"},{"issue":"7554","key":"617_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature14267","volume":"522","author":"ASY Lee","year":"2015","unstructured":"Lee ASY, Kranzusch PJ, Cate JHD. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature. 2015;522(7554):111\u20134.","journal-title":"Nature"},{"issue":"14","key":"617_CR59","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1038\/sj.emboj.7601765","volume":"26","author":"M Masutani","year":"2007","unstructured":"Masutani M, et al. Reconstitution reveals the functional core of mammalian eIF3. Embo J. 2007;26(14):3373\u201383.","journal-title":"Embo J"},{"issue":"1","key":"617_CR60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12967-022-03690-3","volume":"20","author":"R Deng","year":"2022","unstructured":"Deng R, et al. Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC\/AKT axis. J Translational Med. 2022;20(1):485.","journal-title":"J Translational Med"},{"issue":"9","key":"617_CR61","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1111\/jcmm.13128","volume":"21","author":"X Yu","year":"2017","unstructured":"Yu X, et al. TUSC3: a novel tumour suppressor gene and its functional implications. J Cell Mol Med. 2017;21(9):1711\u20138.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"617_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10735-021-10045-7","volume":"53","author":"W Wu","year":"2022","unstructured":"Wu W, et al. Glucose-6-phosphate dehydrogenase promotes the proliferation and migration of lung adenocarcinoma cells via the STAT3 signaling pathway. J Mol Histol. 2022;53(2):215\u201325.","journal-title":"J Mol Histol"},{"issue":"5","key":"617_CR63","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2018.04.012","volume":"27","author":"M Luo","year":"2018","unstructured":"Luo M, Brooks M, Wicha MS. Asparagine and glutamine: Co-conspirators fueling metastasis. Cell Metabol. 2018;27(5):947\u20139.","journal-title":"Cell Metabol"},{"key":"617_CR64","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.biopha.2018.02.100","volume":"101","author":"FM Roversi","year":"2018","unstructured":"Roversi FM, Olalla Saad ST, Machado-Neto JA. Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression. Biomed Pharmacother. 2018;101:278\u201386.","journal-title":"Biomed Pharmacother"},{"key":"617_CR65","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","volume":"8","author":"NB Crux","year":"2017","unstructured":"Crux NB, Elahi S. Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections?? Front Immunol. 2017;8:832.","journal-title":"Front Immunol"},{"key":"617_CR66","doi-asserted-by":"crossref","unstructured":"Hennig P et al. The pathways underlying the multiple roles of p62 in inflammation and cancer. Biomedicines. 2021;9(7).","DOI":"10.3390\/biomedicines9070707"},{"key":"617_CR67","doi-asserted-by":"publisher","first-page":"654344","DOI":"10.3389\/fcell.2021.654344","volume":"9","author":"P Viz\u00e1n","year":"2021","unstructured":"Viz\u00e1n P, Di Croce L, Aranda S. Functional and pathological roles of AHCY. Front Cell Dev Biol. 2021;9:654344.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"617_CR68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.stem.2011.07.010","volume":"9","author":"MM Dawlaty","year":"2011","unstructured":"Dawlaty MM, et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell. 2011;9(2):166\u201375.","journal-title":"Cell Stem Cell"},{"issue":"51","key":"617_CR69","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","volume":"25","author":"MS Hayden","year":"2006","unstructured":"Hayden MS, West AP, Ghosh S. NF-\u03baB and the immune response. Oncogene. 2006;25(51):6758\u201380.","journal-title":"Oncogene"},{"issue":"7","key":"617_CR70","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3868","volume":"49","author":"R Khoueiry","year":"2017","unstructured":"Khoueiry R, et al. Lineage-specific functions of TET1 in the postimplantation mouse embryo. Nat Genet. 2017;49(7):1061\u201372.","journal-title":"Nat Genet"},{"issue":"1","key":"617_CR71","first-page":"179","volume":"10","author":"Y Hu","year":"2020","unstructured":"Hu Y, et al. EIF3H interacts with PDCD4 enhancing lung adenocarcinoma cell metastasis. Am J Cancer Res. 2020;10(1):179\u201395.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"617_CR72","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.21873\/anticanres.11562","volume":"37","author":"M Ueda","year":"2017","unstructured":"Ueda M, et al. Up-regulation of SLC9A9 promotes cancer progression and is involved in poor prognosis in colorectal cancer. Anticancer Res. 2017;37(5):2255\u201363.","journal-title":"Anticancer Res"},{"issue":"5","key":"617_CR73","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/jcmm.17204","volume":"26","author":"F Sun","year":"2022","unstructured":"Sun F, et al. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway. J Cell Mol Med. 2022;26(5):1629\u201342.","journal-title":"J Cell Mol Med"},{"issue":"1\u20132","key":"617_CR74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yexcr.2018.08.012","volume":"373","author":"S Feng","year":"2018","unstructured":"Feng S, et al. TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells. Exp Cell Res. 2018;373(1\u20132):44\u201356.","journal-title":"Exp Cell Res"}],"container-title":["Epigenetics & Chromatin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00617-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13072-025-00617-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00617-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:30:43Z","timestamp":1757377843000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-025-00617-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1186\/s13072-025-00617-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.31.621362","asserted-by":"object"}]},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval of the research protocol by an institutional reviewer board"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration no. of the study\/trial"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}],"article-number":"53"}}